Exact Therapeutics AS Working Capital to Net Assets Ratio
Exact Therapeutics AS working capital to net assets ratio. Exact Therapeutics AS (EXTX) has a Working Capital to Net Assets ratio of 82.7% as of December 2024. Working capital of Nkr95.61 Million (current assets of Nkr133.21 Million minus current liabilities of Nkr37.60 Million) is measured against net assets of Nkr115.55 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Exact Therapeutics AS to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Exact Therapeutics AS (2017–2024)
Working capital to net assets ratio of Exact Therapeutics AS from 2017 to 2024. This chart shows how Exact Therapeutics AS's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of December 2024, the ratio stands at 82.7%, reflecting working capital of Nkr95.61 Million against net assets of Nkr115.55 Million NOK. See Exact Therapeutics AS defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Exact Therapeutics AS Working Capital to Net Assets Ratio by Year (2017–2024)
Exact Therapeutics AS working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Exact Therapeutics AS from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Exact Therapeutics AS asset portfolio.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 82.7% | Nkr95.61 Million | Nkr115.55 Million | Nkr133.21 Million | Nkr37.60 Million | ▼ -6.9 pp |
| 2023 | 89.6% | Nkr40.41 Million | Nkr45.10 Million | Nkr55.90 Million | Nkr15.49 Million | ▼ -4.7 pp |
| 2022 | 94.3% | Nkr61.41 Million | Nkr65.11 Million | Nkr77.53 Million | Nkr16.13 Million | ▼ -1.0 pp |
| 2021 | 95.3% | Nkr100.76 Million | Nkr105.74 Million | Nkr111.30 Million | Nkr10.53 Million | ▼ -1.9 pp |
| 2020 | 97.2% | Nkr155.14 Million | Nkr159.65 Million | Nkr165.71 Million | Nkr10.58 Million | ▲ +0.5 pp |
| 2019 | 96.6% | Nkr40.82 Million | Nkr42.24 Million | Nkr50.65 Million | Nkr9.83 Million | ▼ -3.1 pp |
| 2018 | 99.7% | Nkr56.89 Million | Nkr57.06 Million | Nkr63.06 Million | Nkr6.17 Million | ▲ +3.3 pp |
| 2017 | 96.4% | Nkr8.05 Million | Nkr8.35 Million | Nkr19.73 Million | Nkr11.68 Million | — |